ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1215

Identifying a Pain Signature in Classical Ehlers-Danlos Syndrome: Preliminary Results from Questionnaires and Experimental Pain Testing

Marlies Colman, Inge De Wandele, Lies Rombaut, Delfien Syx, Fransiska Malfait and Jessica Van Oosterwijck, Ghent University, Ghent, Belgium

Meeting: ACR Convergence 2022

Keywords: Collagen, Ehlers-Danlos, pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Fibromyalgia and Other Clinical Pain Syndromes Poster

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Chronic pain is one of the most common complaints of individuals with Ehlers-Danlos syndrome (EDS) and the effects of the existing therapeutical modalities are at best only partially effective. The etiology and mechanisms of pain in EDS have barely been studied, and the current understanding of the underlying neural, molecular and cellular pathways is minimal. Classical EDS (cEDS) is caused by heterozygous alterations in the COL5A1 or COL5A2 gene, encoding type V collagen. Moreover, with an estimated prevalence of 1:20,000, cEDS is the most common molecularly explained EDS type. Our group previously demonstrated an increased sensitivity to mechanical stimuli (mechanical allodynia) and disorganization of the nociceptive innervation in a mouse model for cEDS due to Col5a1 haploinsufficiency. This makes cEDS a highly interesting and suitable EDS type to study pain processing mechanisms.

Methods: Molecularly confirmed cEDS patients (n=20) and age and sex matched healthy controls (n=20) were recruited. Subjective pain was measured using Visual Analogue Scales and symptoms possibly indicating neuropathic pain were evaluated using the PainDETECT and DN4 questionnaires. Forebrain processes that are known to influence pain were studied using several questionnaires (TAMPA scale for kinesiophobia, Hospital Anxiety and Depression scale, Pain Vigilance and Awareness scale, Central Sensitization Inventory and SF-36). Clinical sensitivity to (in)noxious stimuli was studied by measuring pain thresholds for electrical, thermal, vibration, touch, and pressure stimuli. Central pain inhibition was studied using a central pain modulation protocol (CPM) with immersion of one hand in hot water and parallel measurement of pain pressure thresholds.

Results: Individuals with cEDS suffer from significant pain, but no positive scores were found for possible neuropathic pain. The TAMPA scale for Kinesiophobia showed significant kinesiophobia in cEDS. The hospital anxiety and depression scale did not differ between controls and individuals with cEDS, and the SF-36 questionnaire indicated that individuals with cEDS suffer from significant limitations due to physical health but no limitations due do emotional problems. The Pain Vigilance and Awareness questionnaire showed no significant differences compared to controls.Lower pain thresholds were found for pressure and temperature indicating possible hyperalgesia in cEDS. Interestingly, we also found a possible sensory/neurological deficit as individuals with cEDS had higher detection thresholds (for thermal, electrical, mechanical and vibration stimuli), and a significantly higher number of paradoxical heat sensations (errors in distinguishing between warmth or cold sensations) were present upon thermal stimulation. The CPM protocol did show signs of dysfunctional central pain inhibition in individuals with cEDS as the pain pressure thresholds did not differ significantly before, during and after immersion of the hand (as was the case in the control subjects).

Conclusion: cEDS individuals show presence of significant pain, hyperalgesia, a sensory deficit, and deficient central pain inhibition compared to controls.


Disclosures: M. Colman, None; I. De Wandele, None; L. Rombaut, None; D. Syx, None; F. Malfait, None; J. Van Oosterwijck, None.

To cite this abstract in AMA style:

Colman M, De Wandele I, Rombaut L, Syx D, Malfait F, Van Oosterwijck J. Identifying a Pain Signature in Classical Ehlers-Danlos Syndrome: Preliminary Results from Questionnaires and Experimental Pain Testing [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/identifying-a-pain-signature-in-classical-ehlers-danlos-syndrome-preliminary-results-from-questionnaires-and-experimental-pain-testing/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identifying-a-pain-signature-in-classical-ehlers-danlos-syndrome-preliminary-results-from-questionnaires-and-experimental-pain-testing/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology